Beyond Air, Inc. (NASDAQ:XAIR) Short Interest Update

Beyond Air, Inc. (NASDAQ:XAIRGet Free Report) was the recipient of a large growth in short interest in February. As of February 28th, there was short interest totalling 1,530,000 shares, a growth of 27.5% from the February 13th total of 1,200,000 shares. Approximately 2.8% of the company’s stock are sold short. Based on an average trading volume of 1,550,000 shares, the short-interest ratio is presently 1.0 days.

Beyond Air Price Performance

Shares of Beyond Air stock opened at $0.28 on Wednesday. Beyond Air has a 1 year low of $0.24 and a 1 year high of $1.78. The firm has a market cap of $19.52 million, a price-to-earnings ratio of -0.27 and a beta of 0.16. The company has a 50-day moving average of $0.35 and a 200 day moving average of $0.40.

Beyond Air (NASDAQ:XAIRGet Free Report) last posted its quarterly earnings data on Monday, February 10th. The company reported ($0.15) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.09. Beyond Air had a negative return on equity of 226.01% and a negative net margin of 1,730.00%. During the same quarter last year, the firm posted ($0.50) earnings per share. On average, equities analysts anticipate that Beyond Air will post -0.79 EPS for the current year.

Insider Transactions at Beyond Air

In other news, Director Robert Carey acquired 1,000,000 shares of the stock in a transaction on Friday, March 14th. The stock was acquired at an average price of $0.25 per share, with a total value of $250,000.00. Following the completion of the transaction, the director now owns 4,076,864 shares of the company’s stock, valued at $1,019,216. This represents a 32.50 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 20.10% of the company’s stock.

Institutional Trading of Beyond Air

Institutional investors and hedge funds have recently bought and sold shares of the company. Alyeska Investment Group L.P. purchased a new stake in shares of Beyond Air during the fourth quarter valued at $2,560,000. Balyasny Asset Management L.P. bought a new stake in shares of Beyond Air in the fourth quarter worth approximately $1,195,000. Soros Fund Management LLC purchased a new position in shares of Beyond Air during the third quarter valued at approximately $573,000. Baldwin Wealth Partners LLC MA lifted its position in Beyond Air by 721.3% during the fourth quarter. Baldwin Wealth Partners LLC MA now owns 308,000 shares of the company’s stock valued at $110,000 after purchasing an additional 270,500 shares during the period. Finally, Geode Capital Management LLC lifted its position in Beyond Air by 81.0% during the fourth quarter. Geode Capital Management LLC now owns 562,713 shares of the company’s stock valued at $202,000 after purchasing an additional 251,823 shares during the period. 31.50% of the stock is currently owned by institutional investors.

About Beyond Air

(Get Free Report)

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.

See Also

Receive News & Ratings for Beyond Air Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beyond Air and related companies with MarketBeat.com's FREE daily email newsletter.